Literature DB >> 20002576

Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis.

E Hell1, C G Giske, A Nelson, U Römling, G Marchini.   

Abstract

AIMS: The aim of this work was to investigate the possible effect of human cathelicidin antimicrobial peptide LL37 on biofilm formation of Staphylococcus epidermidis, a major causative agent of indwelling device-related infections. METHODS AND
RESULTS: We performed initial attachment assay and biofilm formation solid surface assay in microtitre plates, as well as growth experiment in liquid medium using laboratory strain Staph. epidermidis ATCC35984. We found that already a low concentration of the peptide LL37 (1 mg l(-1)) significantly decreased both the attachment of bacteria to the surface and also the biofilm mass. No growth inhibition was observed even at 16 mg l(-1) concentration of LL37, indicating a direct effect of the peptide on biofilm production.
CONCLUSIONS: As biofilm protects bacteria during infections in humans and allows their survival in a hostile environment, inhibition of biofilm formation by LL37 may have a key role to prevent bacterial colonization on indwelling devices. SIGNIFICANCE AND IMPACT OF THE STUDY: Our findings suggest that this host defence factor can be a potential candidate in prevention and treatment strategies of Staph. epidermidis infections in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002576     DOI: 10.1111/j.1472-765X.2009.02778.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  41 in total

1.  Plant-derived decapeptide OSIP108 interferes with Candida albicans biofilm formation without affecting cell viability.

Authors:  Nicolas Delattin; Katrijn De Brucker; David J Craik; Olivier Cheneval; Mirjam Fröhlich; Matija Veber; Lenart Girandon; Talya R Davis; Anne E Weeks; Carol A Kumamoto; Paul Cos; Tom Coenye; Barbara De Coninck; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

2.  Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation.

Authors:  Katrijn De Brucker; Nicolas Delattin; Stijn Robijns; Hans Steenackers; Natalie Verstraeten; Bart Landuyt; Walter Luyten; Liliane Schoofs; Barbara Dovgan; Mirjam Fröhlich; Jan Michiels; Jos Vanderleyden; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

3.  Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.

Authors:  Berthony Deslouches; Mary L Hasek; Jodi K Craigo; Jonathan D Steckbeck; Ronald C Montelaro
Journal:  J Med Microbiol       Date:  2016-04-05       Impact factor: 2.472

4.  Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.

Authors:  Lauren P Lashua; Jeffrey A Melvin; Berthony Deslouches; Joseph M Pilewski; Ronald C Montelaro; Jennifer M Bomberger
Journal:  J Antimicrob Chemother       Date:  2016-05-26       Impact factor: 5.790

Review 5.  Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions.

Authors:  Nicola Kavanagh; Emily J Ryan; Amro Widaa; Gillian Sexton; Jerome Fennell; Sadhbh O'Rourke; Kevin C Cahill; Cathal J Kearney; Fergal J O'Brien; Steven W Kerrigan
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

6.  Examine the characterization of biofilm formation and inhibition by targeting SrtA mechanism in Bacillus subtilis: a combined experimental and theoretical study.

Authors:  Chandrabose Selvaraj; Jeyachandran Sivakamavalli; Baskaralingam Vaseeharan; Poonam Singh; Sanjeev Kumar Singh
Journal:  J Mol Model       Date:  2014-07-20       Impact factor: 1.810

7.  Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.

Authors:  C Chen; B Deslouches; R C Montelaro; Y P Di
Journal:  Clin Microbiol Infect       Date:  2017-09-04       Impact factor: 8.067

8.  Anti-Staphylococcal Biofilm Effects of Human Cathelicidin Peptides.

Authors:  Biswajit Mishra; Radha M Golla; Kyle Lau; Tamara Lushnikova; Guangshun Wang
Journal:  ACS Med Chem Lett       Date:  2015-12-04       Impact factor: 4.345

9.  Characterization, modes of action, and application of a novel broad-spectrum bacteriocin BM1300 produced by Lactobacillus crustorum MN047.

Authors:  Yingying Lu; Rakhmanova Aizhan; Hong Yan; Xin Li; Xin Wang; Yanglei Yi; Yuanyuan Shan; Bianfang Liu; Yuan Zhou; Xin Lü
Journal:  Braz J Microbiol       Date:  2020-06-14       Impact factor: 2.476

Review 10.  Antibiofilm activity of host defence peptides: complexity provides opportunities.

Authors:  Morgan A Alford; Evan F Haney; Robert E W Hancock
Journal:  Nat Rev Microbiol       Date:  2021-06-28       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.